Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock
-
Yahoo (YHOO) Wasn't Great But It Was Better Than We Feared - Cantor Fitzgerald
-
Yahoo beats Wall Street view, sees Verizon deal closing in second quarter
-
ELS Reports Fourth Quarter Results
-
Ocular Therapeutix (OCUL) Commences Public Offering of Common Stock
-
Ocular Therapeutix, Inc. Announces Public Offering of Common Stock
-
Freddie Mac Prices $1 Billion Multifamily K-Deal, K-061
-
Expect A "Solid" Q3 2017 Report From Alibaba (BABA) - Cantor Fitzgerald
-
Alibaba (BABA): Expect Inline Report - Cantor Fitzgerald
-
PayPal (PYPL): Expecting a Strong Quarter - Cantor Fitzgerald
-
eBay (EBAY) Needs To Show Evidence Of Sustainable Turnaround Before Cantor Fitzgerald Can Become More Constructive
-
FinTech Acquisition Corp. II Announces Pricing of $153,000,000 Initial Public Offering
-
Globalstar to Attend Meetings with J.P. Morgan, Morgan Stanley and Cantor Fitzgerald
-
Zynerba Pharma (ZYNE) Prices 2.8M Shares at $18 Per Share
-
Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Teladoc (TDOC) PT Lowered to $23 at Cantor Fitzgerald Following Offering
-
Heron Therapeutics (HRTX) Prices Offering at $12.20/Share
-
Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
-
Netflix (NFLX) PT Raised to $160 at Cantor Fitzgerald
-
Rambler Metals & Mining PLC: Completion of DMS Trial Testing
-
PlacementTracker Publishes 2016 Private Placement Market League Tables
-
Lies or banter? Ex-Jefferies trader's fate lies with jury
-
Celgene (CELG): Raising Estimates - Cantor
-
Northern Dynasty Announces Increase to Bought Deal Offering of Common Shares
-
Orchid Island Capital Announces January 2017 Monthly Dividend and December 31, 2016 RMBS Portfolio Characteristics
-
Northern Dynasty Announces US$25 Million Bought Deal
-
Bio-Path Holdings (BPTH) Enters $25M At-the-Market Offering Via Cantor Fitzgerald
-
Form D/A Cantor Fitzgerald Wealth
-
College Ave Student Loans Chief Financial Officer Featured Panelist at the 2017 iGlobal Forum’s 7th Specialty Finance Summit
-
Cantor Fitzgerald Remains Sidelined on Humana (HUM) After Adjusting Estimates
-
Cantor Fitzgerald Downgrades CEB (CEB) to Neutral Amid Pending Takeover
-
Harmony Merger Corp. and MUNDOmedia Agree to Combine
-
MUNDOmedia Appoints Ross Levinsohn Executive Chairman of the Board
-
Cantor Fitzgerald Starts NantHealth (NH) at Overweight
-
Cantor Fitzgerald Starts Evolent Health (EVH) at Overweight
-
Cantor Fitzgerald Starts eHealth (EHTH) at Overweight
-
Cantor Fitzgerald Starts Cerner (CERN) at Overweight
-
Cantor Fitzgerald Starts athenahealth (ATHN) at Overweight
-
Cantor Fitzgerald Starts Omnicell (OMCL) at Overweight
-
Cantor Fitzgerald Starts Teladoc (TDOC) at Overweight
-
Cantor Fitzgerald Starts Vocera Communications (VCRA) at Overweight
-
Cantor Fitzgerald Starts Computer Programs and Systems (CPSI) at Neutral
-
Cantor Fitzgerald Starts Castlight Health Inc. (CSLT) at Neutral
-
Cantor Fitzgerald Starts HealthStream (HSTM) at Neutral
-
Cantor Fitzgerald Starts Allscripts (MDRX) at Neutral
-
Cantor Fitzgerald Starts Quality Systems (QSII) at Neutral
-
Ex-Jefferies trader lied to customers, jurors are told
-
Heron Therapeutics (HRTX): Sustinol Trumps Positive HTX-011 Data - Cantor
-
World stocks rise; dollar dips on U.S. labor data, yuan surge
-
Ireland sells 4 billion euros of debut 20-year bond

